Dr. François-Thomas Michaud serves as the Chief Executive Officer at Feldan Therapeutics and is a co-founder of the company.
Dr. Michaud co-founded and became CEO of Feldan in 2007 while completing his Ph.D. degree in chemical engineering. At the time, the company was mainly active in the production and international distribution of bioreagents. In parallel with sales activities, Dr. Michaud and Feldan’s team worked on a research project that led to the inception of proprietary cell-penetrating technology: the Feldan Shuttle. Over the years, Dr. Michaud’s value-creating vision has shaped the business model of the company, which now focuses exclusively on therapeutic development.
Dr. Michaud is actively engaged in corporate, academic, and entrepreneurial communities of the Province of Quebec and Canada as an administrator, speaker, and mentor. He is also a board member of Bio-Québec, Ag Biocentre, and Entrepreneurial Laval.
Sign up to view 15 direct reports
Get started